Delisting riskPopularity #4,270
TELA · NASDAQ · Medical - Devices

TELA Bio (TELA)

Reinforced tissue matrices for hernia and soft-tissue reconstruction.

$1.40
vs last close−0.01 (−0.98%)

13F · 13D/G · Form 4

Institutions57.51%25.75M shares
44 holders · as of Jun 30, 2026
Insiders10.92%4.89M shares
20 holders · as of Sep 18, 2026
Other31.57%14.13M shares
remainder

44.77M company shares as of Sep 23, 2026 · institutions as of Jun 30, 2026 · holders as of their latest filing

13F · 13D/G · Form 4

HolderStakeSharesDate
Essex Woodlands Management, Inc.Institution
17.23%7.71Mas of Jun 30, 2026
Nantahala Capital Management, LLCInstitution
13.17%5.89Mas of Jun 30, 2026
Stonepine Capital Management, LLCInstitution
5.95%2.66Mas of Jun 30, 2026
Lytton, Laurence W.Insider
5.46%2.44Mfiled May 15, 2026
Silverarc Capital Management, LLCInstitution
4.77%2.14Mas of Jun 30, 2026
North Run Capital, LPInstitution
4.43%1.98Mfiled May 30, 2025
Vanguard Capital Management LLCInstitution
3.50%1.57Mas of Jun 30, 2026
Dafna Capital Management LLCInstitution
3.22%1.44Mas of Jun 30, 2026
Perkins Capital Management IncInstitution
3.07%1.38Mas of Jun 30, 2026
Sio Capital Management, LLCInstitution
1.42%636,300as of Jun 30, 2026
Antony KoblishInsiderdirector, officer: Chief Executive Officer
1.31%586,210filed Feb 24, 2026
Heather C. GetzInsiderdirector, officer: Chief Executive Officer
1.19%532,500filed Aug 19, 2026
Wealthtrust Axiom LLCInstitution
1.02%457,734as of Jun 30, 2026
Geode Capital Management, LLCInstitution
0.87%389,223as of Jun 30, 2026
BlackRock, Inc.Institution
0.84%374,516as of Jun 30, 2026
Roberto CucaInsiderofficer: COO and CFO
0.57%257,377filed Feb 24, 2026
Vanguard Fiduciary Trust CoInstitution
0.48%213,138as of Jun 30, 2026
Jeffrey BlizardInsiderofficer: President
0.46%205,125filed Feb 24, 2026
Joseph H. CapperInsiderdirector
0.40%179,827filed Sep 18, 2026
Paul TalmoInsiderofficer: Chief Technology Officer
0.39%173,436filed Feb 24, 2026
Gregory A. FirestoneInsiderofficer: Chief Business Officer
0.31%139,307filed Feb 24, 2026
Up Strategic Wealth Investment Advisors LLCInstitution
0.22%99,888as of Jun 30, 2026
Embree Financial GroupInstitution
0.20%90,906as of Jun 30, 2026
Northern Trust CorpInstitution
0.17%74,790as of Jun 30, 2026
Howard N. LangsteinInsiderofficer: Chief Medical Officer
0.16%71,347filed Mar 11, 2026

13F, as of Jun 30, 2026

44 holders · 25.75M shares · 10 new positions · 21 increased · 10 reduced · 1 closed

HolderShares% outstandingChg q/qFiled
Essex Woodlands Management, Inc.7.71M17.23%0Aug 4, 2026
Nantahala Capital Management, LLC5.89M13.17%+750.0KAug 19, 2026
Stonepine Capital Management, LLC2.66M5.95%+45.2KAug 17, 2026
Silverarc Capital Management, LLC2.14M4.77%−122.1KAug 13, 2026
Vanguard Capital Management LLC1.57M3.50%+27.6KAug 13, 2026
Dafna Capital Management LLC1.44M3.22%0Aug 14, 2026
Perkins Capital Management Inc1.38M3.07%−43.3KJul 24, 2026
Sio Capital Management, LLC636.3K1.42%0Aug 14, 2026

13D/G · 5% or more, as filed

Holder% of classSharesFormFiled
EW Healthcare Partners Fund 2-UGP, LLCincl. Ew Healthcare Partners Fund 2, L.P., Ew Healthcare Partners Fund 2-A, L.P. +1 more17.23%7.71M13DJun 9, 2026
Nantahala Capital Management, LLC12.90%5.11M13GMay 7, 2025
Jon M. Plexicoincl. Stonepine GP, LLC, Stonepine Capital Management, LLC +1 more11.00%2.83M13GOct 29, 2024
Stonepine Capital Management, LLC6.00%2.35M13GFeb 13, 2025
Lytton, Laurence W.5.50%2.44M13GMay 15, 2026
North Run Capital, LP5.00%1.98M13GMay 30, 2025

Form 4

Latest trades

DateInsiderTypeSharesAvg priceOwned after
Sep 17, 2026
Joseph H. Capperdirector
Purchase25,000$1.22179,827
Sep 16, 2026
Joseph H. Capperdirector
Purchase50,000$1.17154,827
Sep 15, 2026
Joseph H. Capperdirector
Purchase50,000$1.06104,827
Sep 14, 2026
Joseph H. Capperdirector
Purchase25,000$1.0254,827
Aug 17, 2026
Heather C. Getzdirector, officer: Chief Executive Officer
Purchase12,500$0.6649532,500
Aug 14, 2026
Heather C. Getzdirector, officer: Chief Executive Officer
Purchase15,000$0.6978520,000
Nov 17, 2025
Ew Healthcare Partners Fund 2, L.P.10 percent owner, other: See Remarks
Purchase3,604,000$1.117,714,709

House and Senate disclosures

Not reported.